StonvexLoading…
StonvexStonvexStonvexCore line items from SSTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $24.18M | $104.13M | $79.34M | $54.24M |
Operating Income | $-6.86M | $-8.73M | $-6.20M | $-4.15M |
Net Income | $-7.00M | $-9.42M | $-6.65M | $-3.12M |
EPS (Diluted) | $-0.54 | $-0.74 | $-0.52 | $-0.36 |
Total Assets | $125.72M | $135.75M | $134.43M | $134.78M |
Total Liabilities | $58.12M | $63.58M | $60.88M | $60.26M |
Cash & Equivalents | $14.24M | $15.80M | $11.83M | $8.95M |
Free Cash Flow OCF − CapEx | $-1.52M | $4.85M | $1.16M | $-3.70M |
Shares Outstanding | 12.95M | 12.83M | 12.70M | 12.79M |